Related Experiment Video
Updated: Jun 30, 2026

Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue
Published on: August 15, 2012
Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity
Kimberly R Byrnes1, Bogdan Stoica, David J Loane
1Department of Neuroscience, Georgetown University Medical Center, 3970 Reservoir Road N.W., Washington, DC 20057, USA. krb27@georgetown.edu
Abstract:
The Group I metabotropic glutamate receptor 5 (mGluR5) can modulate addiction, pain, and neuronal cell death. Expression of some mGluRs, such as Group II and III mGluRs, has been reported in microglia and may affect their activation. However, the expression and role of mGluR5 in microglia is unclear. Using immunocytochemistry and Western blot, we demonstrate that mGluR5 protein is expressed in primary microglial cultures. Activation of mGluR5 using the selective agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) significantly reduces microglial activation in response to lipopolysaccharide, as indicated by a reduction in nitric oxide, reactive oxygen species, and TNFalpha production. Microglial induced neurotoxicity is also markedly reduced by CHPG treatment. The anti-inflammatory effects of CHPG are not observed in microglial cultures from mGluR5 knockout mice and are blocked by selective mGluR5 antagonists, suggesting that these actions are mediated by the mGluR5 receptor. Anti-inflammatory actions of mGluR5 activation are attenuated by phospholipase C and protein kinase C inhibitors, as well as by calcium chelators, suggesting that the mGluR5 activation in microglia involves the G(alphaq)-protein signal transduction pathway. These data indicate that microglial mGluR5 may represent a novel target for modulating neuroinflammation, an important component of both acute and chronic neurodegenerative disorders.
Insights
Activating metabotropic glutamate receptor 5 (mGluR5) in microglia reduces neuroinflammation and neurotoxicity. This finding suggests mGluR5 as a potential therapeutic target for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia play crucial roles in neuroinflammation and neurodegenerative disorders.
- The role of Group I metabotropic glutamate receptor 5 (mGluR5) in microglial function remains largely uncharacterized.
- Previous studies indicate expression of other mGluR groups in microglia, influencing their activation.
Purpose of the Study:
- To investigate the expression and function of mGluR5 in primary microglial cells.
- To determine if mGluR5 activation modulates microglial activation and associated neurotoxicity.
- To elucidate the signaling pathways involved in mGluR5-mediated effects in microglia.
Main Methods:
- Immunocytochemistry and Western blot to confirm mGluR5 expression in microglial cultures.
- Stimulation of microglial cells with lipopolysaccharide (LPS) to induce activation.
- Treatment with the selective mGluR5 agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) and measurement of inflammatory markers.
- Utilized mGluR5 knockout mice and selective antagonists to confirm receptor specificity.
- Investigated downstream signaling pathways using phospholipase C, protein kinase C inhibitors, and calcium chelators.
Main Results:
- mGluR5 protein is expressed in primary microglial cultures.
- CHPG treatment significantly reduced LPS-induced production of nitric oxide, reactive oxygen species, and TNFalpha.
- CHPG administration attenuated microglial-induced neurotoxicity.
- The anti-inflammatory effects of CHPG were dependent on mGluR5 expression and were blocked by antagonists.
- mGluR5 activation in microglia involves the G(alphaq)-protein signal transduction pathway, including phospholipase C, protein kinase C, and calcium signaling.
Conclusions:
- Microglial mGluR5 is expressed and functionally active.
- Activation of microglial mGluR5 exerts potent anti-inflammatory and neuroprotective effects.
- Microglial mGluR5 represents a promising novel therapeutic target for neuroinflammatory and neurodegenerative conditions.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: Glutamate Antagonists

